Strategies to Ramp Up Manufacturing to Meet Global Needs
Interview Details
- Process development, manufacturing, production, operations & facility heads and professionals working on SARS-CoV-2 vaccine development from BIG Pharmas, vaccine manufacturers and research institutions.
- CMOs, technology / service providers and logistics partners keen on understanding how they can alleviate the challenges faced in the manufacturing value chain.
- Strategies to address SARS-CoV-2 vaccine large scale manufacturing challenges from the get-go.
- How CMOs, technology / service providers and other industry stakeholders may step in to fill the gaps in SARS-CoV-2 vaccine manufacturing demand.
- Recommendations on how lessons learnt from this experience can be applied to other emerging infectious diseases and future pandemics.
Meet Our Silver Sponsor
Meet Our Esteemed Panelists
Koh Sok Tiang, VP Scientific Affairs & Technical Services APAC, West Pharmaceutical Services
Ashish Sahai, Director – Viral Vaccines, Serum Institute of India
Li Shi, Chief Scientific Advisor, Former CEO, Shanghai Zerun Biotechnology
Ashley Lauren St. John, Associate Professor, Duke-NUS Medical School
Key Discussion Points
- Reducing process development timelines to a couple of months from a year scale-up plan for COVID-19 vaccines.
- Most of the lead developers in the COVID-19 vaccine race are small and/or inexperienced in large-scale vaccine manufacture.
- What are some of the strategies that could be worked on to ensure co-ordination of vaccine manufacturing and supply chain capability and capacity to meet the demand?
Market Intelligence
In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted of only physical conferences, you can definitely imagine the significant changes that we had to make to business operations to align our […]
INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market. This is due to the high presence of chronic diseases in countries such as China and Japan. With the increased R&D funding, […]
IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop a COVID-19 vaccine. While hosting a phenomenal line-up of frontliners in COVID-19 vaccine development efforts, I had the privilege of gleaning insights […]
Codagenix Inc. recently announced a collaboration project with the Serum Institute of India to develop a live-attenuated vaccine against the current COVID-19 coronavirus. The new coronavirus that has caused fear around the globe causes mild to severe respiratory illnesses with symptoms of coughs and fever. Currently, there are no licensed vaccines to treat the […]
In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted of only physical conferences, you can definitely imagine the significant changes that we had to make to business operations to align our […]
INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market. This is due to the high presence of chronic diseases in countries such as China and Japan. With the increased R&D funding, […]
IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop a COVID-19 vaccine. While hosting a phenomenal line-up of frontliners in COVID-19 vaccine development efforts, I had the privilege of gleaning insights […]
The latest developments of therapeutics and vaccines against the novel coronavirus (COVID-19). 1.Novel broad-spectrum antibiotic compound effective against novel coronavirus A team of researchers has identified new compounds that consist of characteristics against COVID-19 and any other coronaviruses such as SARS-CoV and MERS-CoV. They are working towards a broad-spectrum antiviral that will be used to […]
In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted of only physical conferences, you can definitely imagine the significant changes that we had to make to business operations to align our […]
INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market. This is due to the high presence of chronic diseases in countries such as China and Japan. With the increased R&D funding, […]
IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop a COVID-19 vaccine. While hosting a phenomenal line-up of frontliners in COVID-19 vaccine development efforts, I had the privilege of gleaning insights […]
China announced that they have started its first phase of the clinical trial for a COVID-19 vaccine. Currently no approved vaccines or medication for the new disease, which has killed more than 13,000 people worldwide so far. Scientists around the world race to find a solution against the deadly pathogen. The Chinese effort began […]
In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted of only physical conferences, you can definitely imagine the significant changes that we had to make to business operations to align our […]
INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market. This is due to the high presence of chronic diseases in countries such as China and Japan. With the increased R&D funding, […]
IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop a COVID-19 vaccine. While hosting a phenomenal line-up of frontliners in COVID-19 vaccine development efforts, I had the privilege of gleaning insights […]
Serum Institute of India who has recently announced its collaboration with Codagenix in developing a COVID-19 vaccine expects to progress to the human trial phase within the next 6 months as they have already progressed into pre-clinical tests. Serum Institute of India has been changing the game in the vaccine manufacturing industry with its […]
In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted of only physical conferences, you can definitely imagine the significant changes that we had to make to business operations to align our […]
INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market. This is due to the high presence of chronic diseases in countries such as China and Japan. With the increased R&D funding, […]
IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop a COVID-19 vaccine. While hosting a phenomenal line-up of frontliners in COVID-19 vaccine development efforts, I had the privilege of gleaning insights […]
Pharmaceutical giant, Pfizer recently announced its plans to collaboratively develop a vaccine against COVID-19 with a German biotechnology company, BioNTech. Both companies have signed a letter of intent yesterday (March 17, 2020) in regards to collaborating in developing and distributing a potential mRNA-based coronavirus vaccine to prevent any more infections of the virus. Through […]
In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted of only physical conferences, you can definitely imagine the significant changes that we had to make to business operations to align our […]
INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market. This is due to the high presence of chronic diseases in countries such as China and Japan. With the increased R&D funding, […]
IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop a COVID-19 vaccine. While hosting a phenomenal line-up of frontliners in COVID-19 vaccine development efforts, I had the privilege of gleaning insights […]
Johnson & Johnson said that they will begin on developing and manufacturing a new coronavirus vaccine with the U.S. government, after seizing over $1 billion deal with them. They would be working closely with Biomedical Advanced Research and Development Authority (BARDA), an arm of the U.S. Department of Health and Human Services to extensively […]
English 
简体中文 
日本語 
한국어 
繁體中文